NEUROCRINE BIOSCIENCES INC — Form 8-K
Filed September 28, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Form 8-K filed 2026-09-28 disclosing Item 5.02 regarding departure of directors or officers, election of directors, appointment of officers, and compensatory arrangements. No specific names, dollar amounts, dates of departure, or compensation details are provided in the filing header or accessible document summary.
Why this rating
Standard officer/compensation disclosure with no quantitative specifics revealed. Routine 8-K filing; lack of concrete details prevents material assessment.
Extracted items
See more from September 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.